VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+5.45%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
+$6.44M
(+2.7%)
Cap. Flow
-$3.44M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
7.68%
Holding
410
New
55
Increased
156
Reduced
186
Closed
11
Top Buys
| 1 |
BKCC
BlackRock Capital Investment Corporation
BKCC
|
$670K |
| 2 |
Zai Lab
ZLAB
|
$520K |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$422K |
| 4 |
DRD
DRDGold
DRD
|
$405K |
| 5 |
Stellus Capital Investment Corp
SCM
|
$402K |
Top Sells
| 1 |
AMRS
Amyris Inc.
AMRS
|
$1.28M |
| 2 |
Prothena Corp
PRTA
|
$971K |
| 3 |
BioNTech
BNTX
|
$787K |
| 4 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$647K |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$645K |
Sector Composition
| 1 | Healthcare | 27.38% |
| 2 | Real Estate | 18.81% |
| 3 | Energy | 13.29% |
| 4 | Materials | 10.7% |
| 5 | Utilities | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Shattuck Labs
STTK
$74.2M
| $228K | 0.09% |
+7,854
| New | +$228K |
|
|
ISEE
252
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $228K | 0.09% |
36,079
-7,188
| -17% | -$45.4K |
|
|
ARNA
253
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $228K | 0.09% |
3,350
-923
| -22% | -$62.8K |
|
|
AFMD
254
DELISTED
Affimed
AFMD
| $227K | 0.09% |
2,676
-1,595
| -37% | -$135K |
|
255
Legend Biotech
LEGN
$6.66B
| $227K | 0.09% |
5,531
-4,485
| -45% | -$184K |
|
256
TG Therapeutics
TGTX
$5.11B
| $227K | 0.09% |
5,840
-1,028
| -15% | -$40K |
|
|
NGM
257
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $227K | 0.09% |
11,501
+627
| +6% | +$12.4K |
|
|
CCXI
258
DELISTED
ChemoCentryx, Inc.
CCXI
| $227K | 0.09% |
16,985
+12,216
| +256% | +$163K |
|
259
Relmada Therapeutics
RLMD
$54.8M
| $226K | 0.09% |
7,056
-1,891
| -21% | -$60.6K |
|
260
Xenon Pharmaceuticals
XENE
$3.02B
| $225K | 0.09% |
12,091
-12,728
| -51% | -$237K |
|
|
TPTX
261
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $225K | 0.09% |
2,880
+514
| +22% | +$40.2K |
|
262
Curis
CRIS
$21M
| $224K | 0.09% |
+1,386
| New | +$224K |
|
263
PMV Pharmaceuticals
PMVP
$77.4M
| $224K | 0.09% |
+6,556
| New | +$224K |
|
|
IMGN
264
DELISTED
Immunogen Inc
IMGN
| $224K | 0.09% |
33,943
-7,416
| -18% | -$48.9K |
|
265
Axsome Therapeutics
AXSM
$6.25B
| $223K | 0.09% |
3,313
-445
| -12% | -$30K |
|
266
Crinetics Pharmaceuticals
CRNX
$3.35B
| $223K | 0.09% |
11,810
-10,072
| -46% | -$190K |
|
267
Korro Bio
KRRO
$312M
| $223K | 0.09% |
448
+284
| +173% | +$141K |
|
|
GMDA
268
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $223K | 0.09% |
34,842
+1,800
| +5% | +$11.5K |
|
|
TVRD
269
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $222K | 0.09% |
433
-127
| -23% | -$65.1K |
|
|
CLVS
270
DELISTED
Clovis Oncology, Inc.
CLVS
| $222K | 0.09% |
+38,303
| New | +$222K |
|
271
XBiotech
XBIT
$89M
| $221K | 0.09% |
13,346
-2,526
| -16% | -$41.8K |
|
|
RETA
272
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $221K | 0.09% |
1,560
-977
| -39% | -$138K |
|
273
Alector
ALEC
$305M
| $220K | 0.09% |
10,556
-9,361
| -47% | -$195K |
|
274
Immunocore
IMCR
$1.87B
| $220K | 0.09% |
+5,634
| New | +$220K |
|
275
Immunovant
IMVT
$2.99B
| $220K | 0.09% |
20,827
+14,684
| +239% | +$155K |
|